Aripiprazole in young people with early psychosis: a systematic review and meta-analysis of weight gain

Aripiprazole in young people with early psychosis: a systematic review and meta-analysis of weight gain

Forfattere
Parmar, A. Hulme, D. Hacking, D. Shymko, G. Dragovic, M. Terina, G. Waters, F.
Årstall
2022
Tidsskrift
Australasian Psychiatry
Volum
Sider
10398562211037334
OBJECTIVE Aripiprazole is often prescribed to young people, although there remain unanswered questions about its effects on weight gain. This study undertook a meta-analysis of weight gain occurring in young people with early psychosis who were prescribed aripiprazole. METHOD A systematic search was conducted for studies reporting on aripiprazole and weight change in young people with a psychotic disorder. A meta-analysis integrated the data into an estimate of effect size. RESULTS Eleven studies met the inclusion criteria amounting to 886 participants (mean age 18 years). The results showed significant weight gain averaging 2.7 kg. These increases were associated with a longer duration of exposure to aripiprazole but not a higher dosage. CONCLUSIONS The results highlight the importance of regular patient monitoring and the early implementation of interventions to manage antipsychotic-related weight gain.

Oversett med Google Translate
-
Tiltaksnivå

Behandling og hjelpetiltak

Tema

Psykiske vansker og lidelser

Andre problemer

Psykose

Biologiske risikofaktorer, sykdommer og symptomer

Bivirkninger/uønskede effekter

Tiltak

Medikamentell behandling

Antipsykotisk medisin

Aldersgruppe

Ungdom (13-18 år)

Mer informasjon
Leter du etter mer informasjon om temaet? Trykk på lenkene nedenfor for å søke i PsykTestBarn og Tiltakshåndboka for barn og unges psykiske helse.